Introduction
Nasopharyngeal carcinoma (NPC) has a distinct histopathology and geographic distribution compared with other cancers of the head and neck (1, 2) . The incidence in Southern China and South-East Asia (endemic areas) is high with the majority of tumors being undifferentiated, non-keratinizing carcinomas (3, 4) . On the contrary, NPCs of non-endemic areas (such as Northern Europe) can be keratinizing or non-keratinizing (5) .
The mortality rate of NPC in both endemic and non-endemic areas is high even in cases diagnosed at an early stage (6) . On the basis of GLOBOCAN worldwide estimates of cancer incidence and mortality, 86 700 new cases of NPC were diagnosed in 2012, and were associated with 50 800 deaths (1) . As in other cancers, variations in clinical outcome of NPC were noted even between cases diagnosed at the same stage and receiving similar treatments (7) . This emphasizes the need to identify markers that can predict the behavior of an individual NPC. Such markers would be very important for treatment planning.
For histopathologic diagnosis of NPC, pathologists recognize an infiltrate of lymphocytes and plasma cells between tumor islands and some of these lymphocytes and plasma cells penetrate the tumor islands. However, the pathology report of NPC does not include assessment of the host immune response.
There is a need to identify reliable histopathologic markers to evaluate the immune response in routine hematoxylin and eosin (HE) stained slides. Such parameters/markers could facilitate prediction of patient outcome and assist in treatment planning. Interestingly, NPC is also known as lymphoepithelial carcinoma due to the presence of an abundant population of non-neoplastic lymphocytes (8) . However, the number of these lymphocytes varies from one tumor to another and sometimes also varies between the tumoral and stromal parts of the same tumor (9) .
In various epithelial tumors, tumor-infiltrating lymphocytes (TILs) infiltrate tumor islands and the associated stroma (10, 11) . A recent meta-analysis including different subsites of head and neck cancers confirmed the prognostic significance of specific TILs (namely, intra-tumoral CD3+ and CD8+) (12).
Overall assessment of TILs using routine HE-stained slides has been recently reported for many cancers (13) (14) (15) . However, there are currently no studies that have evaluated TILs using routine HE slides in NPCs of non-endemic regions. We sought to analyze the prognostic significance of TILs in a Finnish multicenter nationwide cohort of NPC that includes both keratinizing and non-keratinizing types.
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Material and Methods
We identified 169 patients treated for NPC at the five Finnish university hospitals (Helsinki, Turku, Tampere, Kuopio and Oulu) or in regional central hospitals. All cases were diagnosed between 1990 and 2009, and they were staged according to the International Union Against Cancer (UICC) staging system, 7th edition (16 TILs ( Fig. 1 ) were evaluated separately for the tumoral compartment and the stromal compartment.
The quantity of intra-tumoral TILs was defined as the percentage of tumor islands/nests occupied by infiltrating lymphocytes. The quantity of stromal TILs was scored as the percentage of stromal areas occupied by infiltrating lymphocytes. Stroma not related to a tumor was not considered. TILs were assessed on HE-stained diagnostic sections. For evaluation of TILs, we followed a practical review for pathologists recently introduced by the International Immuno-Oncology Biomarkers Working Group (17) , which classifies TILs into intra-tumoral TILs and stromal TILs. We evaluated TILs within the borders of the invasive tumors, and assessment of the average amount of TILs was performed as introduced in the recent guidelines (13) . At least five fields were evaluated to assess the average of TILs. A training session to familiarize with the scoring criteria was guided by an experienced head and neck pathologist (IL). An independent researcher (AA) scored all cases and all scores were then reviewed by the pathologist (IL).
Another experienced pathologist (JH), who did not participate in the training session, was invited to score about one third of the cohort (45 cases) randomly selected in order to evaluate the agreement between pathologists.
Data analysis:
We used the kappa coefficient to evaluate the agreement between pathologists. The relationship between intra-tumoral TILs and the age of the patient, gender, TNM stage, type of histopathology, and stromal TILs was analyzed by cross-tabulation. The statistical significance of factors associated with intra-tumoral TILs was evaluated using the chi-square test.
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We then analyzed overall survival (OS) and disease-specific survival (DSS). The date of diagnosis was the starting point for calculation of survival time. Death from any cause or from NPC were defined as the events to be studied. We analyzed the prognostic value of intra-tumoral TILs (at a 5% cutoff point),
stromal TILs (at a 10% cutoff point) and type of histology. Then we designed a histopathologic prognostic model that includes both intra-tumoral TILs (low or high) and the type of histology (keratinizing or nonkeratinizing) as follows: low-risk (non-keratinizing tumors with high intra-tumoral TILs), intermediate-risk
(non-keratinizing tumors with low intra-tumoral TILs or keratinizing tumors with high intra-tumoral TILs), and high-risk (keratinizing tumors with low intra-tumoral TILs). Kaplan-Meier survival curves were drawn separately for OS and DSS events by intra-tumoral TILs, stromal TILs, and our proposed histopathologic model. The log-rank test was used to evaluate the statistical significance of differences between the survival curves.
We estimated multivariable Cox regression models to verify the effects of significant prognosticators when age and stage were adjusted. The models were estimated separately for each prognostic variable. For the models, hazard ratios (HR) and 95% confidence intervals (CI) were reported with the additional information likelihood ratio test (18) . The assumptions of the Cox regression model were checked graphically by Kaplan-Meier curves.
We used IBM SPSS Statistics (version 24) and MedCalc (version 18) for all statistical analyses. A P value < 0.05 was considered statistically significant.
Results
The clinicopathological characteristics of our whole population-based cohort are summarized in Table 1 
There was a moderate agreement between the pathologists in categorizing the tumors into groups with low or high TILs (kappa value of 0.6).
TILs were noted in most of our cases with a variation in percentage from one case to another. Many more TILs were observed in the stroma compared with the tumor parts. In general, the quantity of stromal and intra-tumoral TILs were positively correlated with each other (two-sided; P <0.001). High percentages of intra-tumoral lymphocytes were seen more often in young patients (two-sided; P = 0.03), and were also found more often in non-keratinizing undifferentiated tumors (two-sided; P <0.001). Stromal lymphocytes associated with the type of histology (P = 0.005), while association with patient age was less significant (two-sided, P = 0.05). There was no correlation between TILs (either intra-tumoral or stromal) with gender or stage (two-sided, P >0.05). There was a significant association between Epstein-Barr virus (EBV) status and TILs (Table 1) , where EBV-positive tumors had high intra-tumoral and stromal TILs (P <0.001).
Univariable analysis ( Tumors with low stromal TILs were associated with poor OS (HR 2.04, 95%CI 1.26-3.33, P = 0.004) but the prognostic value was not statistically significant for DSS (HR 1.62, 95%CI 0.89-2.94, P = 0.11). We tested different cutoff points (5%, 10%, 20%, 30%, 40%, 50%, 60%, 70%, 80%) to stratify the tumors into low or high stromal TILs; and the best prognostic value was at 10%. In the Cox regression model ( Table 2 and 3) for multivariable analysis, intra-tumoral TILs showed a significant correlation with OS (HR 2.55, 95%CI
1.60-4.05, P < 0.001) and DSS (HR 2.02, 95%CI 1.16-3.52, P = 0.015). While stromal TILs associated with OS (HR 1.78, 95%CI 1.08-2.93, P = 0.025), the association with DSS was not statistically significant (HR 1.37, 95%CI 0.75-2.53, P = 0.31).
In univariable analysis, the combination scores of intra-tumoral TILs with type of histology were significantly associated with poorer OS (HR 3.40, 95%CI 1.91-6.07, P < 0.001) and poorer DSS (HR 2.86, 95%CI 1.42-5.77, P = 0.003) for keratinizing tumours with low TILs. In multivariable analysis, a higher
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score in our prognostic model was significantly associated with poorer OS (HR 3.94, 95%CI 2.17-7.15, P < 0.001) and DSS (HR 2.97, 95%CI 1.46-6.05, P = 0.009).
In multivariable analysis, most of the clinicopathologic factors were not useful for prognostication except clinical stage, which was a significant prognostic factor for OS (HR 2.12, 95%CI 1.28-3.50, P = 0.003) and DSS (HR 3.53, 95%CI 1.75-7.10, P < 0.001). Of note, EBV-negative tumors had a worse OS (HR 3.54, 95%CI 2.00-6.25, P < 0.001) and DSS (HR 2.63, 95%CI 1.37-5.05, P = 0.004) than EBV-positive tumors in the multivariable analysis.
Discussion
The host immune response has a significant role in the clinical behavior of NPC and in many other cancers.
It is well known that similar tumors at the same stage may have extreme variations in their immune responses (19) . Consequently, the immunological heterogeneity of NPC might be useful for identifying different prognostic categories. The prognostic impact of TILs has been recently reported in many cancers (20) (21) (22) (23) . Here, we visually assessed TILs in NPC using HE-stained diagnostic slides. This method is simple and has the potential to successfully assess the behavioral pattern of NPC and even to predict survival.
We noted that intra-tumoral TILs are significantly associated with both OS and cancer-related mortality (i.e. DSS). However, while there was an association between stromal TILs and survival, this was statistically significant for OS but not significant for DSS. Similarly, in a study of ovarian cancer, James et al (14) found an association between prognosis and both intra-tumoral and stromal TILs, but the relationship was statistically significant for intra-tumoral TILs only. Notably, a recent Chinese study by Wang et al from an endemic area (15) showed that TILs, specifically stromal TILs, are a promising prognostic factor for NPC. It is important to note that all their cases were non-keratinizing undifferentiated NPCs (15) . We emphasize that our NPC cases from a non-endemic area are histopathologically different including both keratinizing and non-keratinizing types. Biological distinctions between our cohort and that of Wang et al (15) might also exist as development of NPC in endemic regions is thought to be associated with etiologic factors different from those in non-endemic regions (24) .
TILs in NPC have been studied recently using immunohistochemistry (25, 26) . However, assessment of TILs using just HE staining is an attractive and simple alternative, which has been used in evaluating TILs
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in various cancers (13, 22, 27) . Evaluation of TILs using HE-stained slides was easily applicable in this study and in previous studies that also reported good reproducibility between pathologists (10, 27, 28) . These two advantages (routine staining method and good reproducibility) make TILs a candidate eligible to be included in pathology reports of NPC.
In this study, we assessed the number of TILs semiquantitatively as a continuous variable according to the recommendation of the International Immuno-Oncology Biomarkers Working Group, which has defined no risk threshold between high and low amount of TILs in NPC (17) . Therefore, we have tested different cutoff points (5%, 10%, 20%....etc) to sort out tumors with low or high TILs. The highest prognostic significance of intra-tumoral TILs for both OS and DSS was reported with a cutoff point at 5%.
This cutoff point was recently identified as the optimal cutoff point in colorectal cancer (29) . Moreover, in a recent study of lung cancer, tumors with TILs ≤5% had the worst OS and DSS (27) . Digital imaging systems have the potential of high accuracy and reproducibility. Therefore, they could be considered for further assessment of TILs in NPC.
The International Immuno-Oncology Biomarkers Working Group (17) recently published a practical review for pathologists and proposed to standardize the method of assessing TILs in different tumors, including those of the head and neck region. They explained that the pre-existing lymphoid stroma can complicate the evaluation of stromal TILs in some head and neck tumors and therefore, it is better to focus on intra-tumoral TILs (17) . Such anatomic circumstances might explain why stromal TILs were not significantly associated with NPC-related mortality in our cohort. Therefore, we suggest the reporting of intra-tumoral TILs in NPC.
Our results identified a group of NPC cases that are at high risk of cancer-related mortality. Patients in this group have a keratinizing tumor with a low amount of intra-tumoral TILs. Of note, the combination of these two features has prognostic power superior to each one individually. Our proposed model has the potential to help clinicians in treatment planning and recommends the choice of multimodality approach for such NPC cases. The standard treatment of radiotherapy may not be sufficient for those cases. A more aggressive treatment (e.g. definitive chemoradiotherapy and neck dissection for residual neck disease) might be necessary for keratinizing tumors with low intra-tumoral TILs. Recent research has highlighted the
usefulness of immunotherapy for some cancers (30, 31) , and further research is necessary to evaluate the benefits of such therapies for NPC with low intra-tumoral TILs.
Recent studies on different cancers have reported a significant association between improved survival and high TILs (21, 27, 32) . However, the exact mechanism by which TILs affect the prognosis is not well understood. Generally, the predominance of TILs has been claimed to reflect an effective anti-tumor immune response (33, 34) . Delayed tumor progression due to high TILs was also suggested (35) . Of note, progression of many cancers was accompanied by severe immune suppression (36) . Such insights indicate that an increase in TILs will enhance anti-tumor activities improving survival. A more specific speculation suggested that suppression of the epithelial-mesenchymal transition in breast cancer with eribulin chemotherapy can enhance the immune response against the tumor by improving the cancer immune microenvironment (37) . Therefore, TILs can be used to monitor the host immune response to cancer and to predict therapeutic efficacy (37) .
One limitation of our study is the small number of cases, despite being a nationwide study. This is because NPC is an uncommon tumor in non-endemic areas such as Finland. For larger cohorts further research should involve international collaborative efforts from other non-endemic regions. Moreover, our study did not provide any evidence on how TILs influence NPC. Also, our study is retrospective, and prospective studies would be needed before TILs can be included in daily practice as a factor determining survival. Despite these limitations, our findings from a non-endemic region (Finland) and recent findings (15) in an endemic region (China) strongly indicate that evaluation of TILs can be easily performed in routine HE-stained slides and has a significant value in assessing survival. A: High TILs, which infiltrate in both tumor islands and the stroma (HE-stain).
Figure legend
B: An example of scarcity of TILs in a case of NPC (HE-stain).
C: keratinizing NPC with low TILs (Van Gieson stain).
Abbreviations:
TILs: tumor-infiltrating lymphocytes, NPC: nasopharyngeal carcinoma, HE: hematoxylin and eosin. 
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Highlights  Low intra-tumoral TILs associated with worse OS and DSS in NPC.
 Aggressive treatment might be necessary for keratinizing NPC with low TILs.
 TILs are a simple to measure, and valid prognostic factor. 
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